Tenax Therapeutics (TENX) Profit After Tax (2016)
Historic Profit After Tax for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$33.9 million.
- Tenax Therapeutics' Profit After Tax fell 17972.22% to -$33.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$54.9 million, marking a year-over-year increase of 6433.49%. This contributed to the annual value of -$17.6 million for FY2024, which is 12827.13% down from last year.
- As of Q4 2016, Tenax Therapeutics' Profit After Tax stood at -$33.9 million, which was down 17972.22% from -$4.3 million recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' Profit After Tax registered a high of $107.6 million during Q2 2012, and its lowest value of -$117.0 million during Q2 2013.
- Its 4-year average for Profit After Tax is -$9.2 million, with a median of -$4.6 million in 2016.
- Over the last 5 years, Tenax Therapeutics' Profit After Tax had its largest YoY gain of 367659.93% in 2012, and its largest YoY loss of 38687.41% in 2012.
- Tenax Therapeutics' Profit After Tax (Quarter) stood at -$1.6 million in 2012, then tumbled by 7415.94% to -$117.0 million in 2013, then skyrocketed by 89.66% to -$12.1 million in 2015, then plummeted by 179.72% to -$33.9 million in 2016.
- Its Profit After Tax was -$33.9 million in Q4 2016, compared to -$4.3 million in Q3 2016 and -$4.6 million in Q2 2016.